SARS-CoV-2 Nucleoprotein Rabbit pAb - P0DTC9

Core Product Specifications and Parameters

Experimental Guidance and Technical Tips

• The immunogen spans the full-length Nucleoprotein (aa 1-419), suggesting this polyclonal antibody may recognize both native and denatured epitopes. For WB and DB, standard direct antigen-coating or blotting protocols can be optimized.
• For IF/ICC, consider testing multiple fixation methods (e.g., paraformaldehyde vs. methanol) to preserve epitope accessibility; validate in a relevant SARS-CoV-2-infected cell system.
• In IP applications, polyclonal antibodies often enrich the target efficiently due to multi-epitope recognition; confirm elution conditions experimentally.
• For ELISA, this antibody may serve as either capture or detection reagent; pairing with a matched monoclonal antibody could improve assay specificity. Validate in the intended sample matrix.
• Cross-reactivity is reported as specific for SARS-CoV-2; if you need reactivity with other coronaviruses, perform a cross-reactivity assessment before use.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio bridges the gap between raw-material innovators and diagnostic developers by providing one-stop access to validated IVD core reagents. This anti-SARS-CoV-2 Nucleoprotein polyclonal antibody can be reliably sourced through our supply network, alongside complementary offerings such as optimized monoclonal antibodies, bulk ancillary reagents, and custom raw-material sourcing for rare targets. Whether you are advancing COVID-19 diagnostics or building panels for respiratory virus detection, CamelBio supports your journey from concept to clinic with B2B-focused sourcing consistency.